Percent of Male Medicare Beneficiaries Age 75 and Older Having a Screening PSA Test
  • Print
  • PDF
  • Embed

    Copy the following code and paste it into your website in order to display the current report.

  • Download to Excel

Customize Report

    • YEAR:

    Choose Locations

    [clear all] [select all] Selected Locations:

      Choose Indicator(s)

      Select one or more indicators
      • TOPIC:
      • INDICATOR:
      • YEAR:

      [clear all] Selected Indicators:


    (Click a region name to the left to view its profile)
    Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming National Average 90th Percentile 50th Percentile 10th Percentile
    Percent of Male Medicare Beneficiaries Age 75 and Older Having a Screening PSA Test
    (Year: 2014; Region Levels: State)
    23.2% 12.6% 18.9% 18.2% 18.9% 12.8% 16.7% 17.2% 15.0% 23.0% 21.9% 19.9% 14.2% 18.0% 17.1% 14.3% 18.3% 18.0% 20.5% 9.6% 15.9% 15.1% 20.8% 10.5% 19.8% 16.8% 14.0% 16.1% 15.3% 12.0% 21.2% 13.3% 21.6% 17.7% 16.1% 17.3% 18.6% 12.6% 17.0% 16.7% 19.9% 15.8% 20.8% 19.0% 14.1% 9.7% 15.3% 12.6% 17.2% 12.1% 11.1% 18.2% 20.8% 16.8% 12.1%
        • FOOTNOTES:
        • PSA screening rates are not adjusted; because the measure is already restricted by age and sex, statistical adjustments to correct for underlying population differences are not relevant.

        • The denominator consisted of male Medicare enrollees age 75-99 on January 1, 2012 who were eligible for Medicare Parts A and B and not enrolled in risk-bearing HMOs at any time during the year. Excluded from the analysis were men who had a PSA test for a presumed screening indication, men who had any history of prostate disease (prostate cancer, prostate surgery, or diagnosis of elevated PSA in the prior three years), and men who had prostate cancer-like symptoms in the three months before a PSA test based on diagnostic codes billed on visits and hospitalizations.

        • PSA screening was defined as any, but only one occurrence per patient during 2012 of CPT codes G0103 and 84153.


    © 2018 The Trustees of Dartmouth College | 35 Centerra Parkway, Lebanon, NH 03766 | (603) 653-0800

    The Dartmouth Atlas of Health Care is based at The Dartmouth Institute for Health Policy and Clinical Practice and is supported by a coalition of funders led by the Robert Wood Johnson Foundation, including the WellPoint Foundation, the United Health Foundation, the California HealthCare Foundation, and the Charles H. Hood Foundation.